| MedicationIPS (Medication) | S | | http://hl7.org/fhir/StructureDefinition/Medication | There are no (further) constraints on this element Element idMedication CommentsData typehttp://hl7.org/fhir/StructureDefinition/Medication |
| id | S | | | There are no (further) constraints on this element Element idMedication.id |
| meta | S | | | There are no (further) constraints on this element Element idMedication.meta |
| code | S | 1..1 | Codeable Concept (IPS) | There are no (further) constraints on this element Element idMedication.code Short descriptionMedication that was administered or was to be administered. Several kinds of product coding could be provided as: the IDMP Pharmaceutical Product Identifiers (PhPID), the IDMP Medicinal Product Identifier (MPID), the IDMP Packaged Medicinal Product Identifier (PCID), when they will be available; the WHO ATC code; or any other kind of code that identifies, classifies or clusters the administered product (such as SNOMED CT, RxNorm, jurisdictional code systems, cross-jurisdiction code systems, or any other classification). DefinitionMedication that was administered or was to be administered.
Several kinds of medication coding could be provided as:
- The IDMP Pharmaceutical Product Identifier (PhPID), Level 1, [Substance(s)]. Example: Amoxicillin and Clavulanate Potassium; or any other equivalent coded concept;
- The IDMP Pharmaceutical Product Identifier (PhPID), Level 2 [Substance(s) + Strength + reference strength]. Example: Amoxicillin 875 mg and Clavulanate Potassium 125 mg; or any other equivalent coded concept;
- The IDMP Pharmaceutical Product Identifier (PhPID), Level 3 [Substance(s) + administrable dose form]. Example: Amoxicillin and Clavulanate Potassium, Oral Tablet; or any other equivalent coded concept;
- The IDMP Pharmaceutical Product Identifier (PhPID), Level 4 [Substance(s) + strength + reference strength + administrable dose form]. Example: Amoxicillin 875 mg and clavulanate potassium 125 mg, oral tablet; or any other equivalent coded concept 5. The IDMP Medicinal Product Identifier (MPID) or any equivalent Medicinal Product Identifier. IDMP MPID uniquely identifies a Medicinal Product, reflecting (but not replacing) any other authorization numbers allocated by a regulator. MPID implies one (set of) PhPID. The MPID shall use a common segment pattern related to a Medicinal Product, which, when each segment is valued shall define a specific MPID concept.
- The IDMP Packaged Medicinal Product Identifier (PCID) or any equivalent Packaged Medicinal Product Identifier. Uniquely identifies a Medicinal Product based on its packaging. This implies one MPID can be associated with more than one PCID, if the same Medicinal Product has more than one type of package.
- Any other kind of code that that identifies, classifies or cluster the administered product (e.g. the medicinal product or the product class)
The value sets used for the PhPID, MPID and PCID identifiers are provisional and include only few equivalent concepts used for exemplification purposes, they will be updated with real IDMP identifiers when they will become available.
Codeable Concept (IPS) BindingThe type of medication Medication_codes_uv_ips (example) |
| coding | | 1.. | | There are no (further) constraints on this element Element idMedication.code.coding SlicingUnordered, Open, by system(Value) Discriminated by code system |
| atcClass | | ..1 | Binding | There are no (further) constraints on this element Element idMedication.code.coding:atcClass Short descriptionWHO ATC classification DefinitionBindingWHOATC (required) |
| system | | 1.. | Fixed Value | There are no (further) constraints on this element Element idMedication.code.coding:atcClass.system Fixed valuehttp://www.whocc.no/atc |
| form | S | | Codeable Concept (IPS)Binding | There are no (further) constraints on this element Element idMedication.form DefinitionDescribes the form of the item. Powder; tablets; capsule.
Administrable Pharmaceutical Dose Form.
This code represents the form of the medication (e.g. tablet, capsule, liquid)
Since the EDQM Standards Terms, together with UCUM, is one of the IDMP terminologies actually available for usage, this code system has been selected as referecne terminology for representing Pharmaceutical Dose forms;Pakages and Route of Administration.
It is known that also alternative jurisdictional and international terminologies are known to be used for this concept domain, as NCI or SNOMED CT.
Codeable Concept (IPS) BindingIPSDoseForm (preferred) |
| amount | | | Ratio | There are no (further) constraints on this element Element idMedication.amount Data typeRatio |
| ingredient | S | | | There are no (further) constraints on this element Element idMedication.ingredient |
| itemCodeableConcept | S | | Codeable Concept (IPS)Binding | There are no (further) constraints on this element Element idMedication.ingredient.itemCodeableConcept:itemCodeableConcept CommentsThe IDMP ISO 11238 standard addresses the identification and exchange of regulated information on substances.
The Global Ingredient Archival System (GInAS) will provide a common global identifier for all of the substances used in medicinal products, providing a definition of substances globally consistent with this standard.
Those identifiers however are yet available for concrete usage, therefore in this version of the template, SNOMED CT has been chosen as reference terminology also for the active substances.
This choice will be revised based on the availability and the maturity of GInAS.
Codeable Concept (IPS) BindingSNOMED CT drug substances IPSActiveSubstances (preferred) |
| text | S | | | There are no (further) constraints on this element Element idMedication.ingredient.itemCodeableConcept:itemCodeableConcept.text |